Ricardo Roque

Team icon

Publications

Show less

Information about journal articles, updated at 07-06-2026, from platform CIÊNCIAVITAE.

Genomic Pathway Alterations and Their Prognostic Impact in Biliary Tract Cancer: Insights from a Multinational Cohort Treated with Cisplatin, Gemcitabine, and Durvalumab

Chiara Pirrone; Umberto Malapelle; Francesco Pepe; Federica Lo Prinzi; Federico Nichetti; Anna Saborowski; Lorenzo Antonuzzo; et al, European Journal of Cancer. 2025. http://dx.doi.org/10.1016/j.ejca.2025.116035 . 10.1016/j.ejca.2025.116035 . European Journal of Cancer

The role of progesterone in ovarian cancer from pathogenesis to personalized therapy: an updated mini-review

European Journal of Gynaecological Oncology. 2025. http://dx.doi.org/10.22514/ejgo.2025.126 . 10.22514/ejgo.2025.126 . European Journal of Gynaecological Oncology

A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC-D Index

Mara Persano; Margherita Rimini; Francesca Salani; Federica Lo Prinzi; Federico Nichetti; Anna Saborowski; Lorenzo Antonuzzo; et al, Liver International. 2025. http://dx.doi.org/10.1111/liv.70181 . 10.1111/liv.70181 . Liver International

Factors associated with reaching maintenance therapy in patients with advanced biliary tract cancer treated with durvalumab: Real-world results from a multicenter and multinational study

Margherita Rimini; Lorenzo Fornaro; Federica Lo Prinzi; Mario Domenico Rizzato; Anna Saborowski; Lorenzo Antonuzzo; Federico Rossari; et al, International Journal of Cancer. 2025. http://dx.doi.org/10.1002/ijc.35481 . 10.1002/ijc.35481 . International Journal of Cancer

REAL-WORLD OUTCOMES OF ANTI-EGFR RECHALLENGE GUIDED BY LIQUID BIOPSY IN METASTATIC COLORECTAL CANCER

Ricardo Roque; Rita Antunes Santos; Luis Guilherme Santos; Rita Coelho; Isabel Viera Fernandes; Gonçalo Cunha; Marta Gonçalves; Judy Paulo; Nuno Bonito, GE - Portuguese Journal of Gastroenterology. 2025. http://dx.doi.org/10.1159/000544044 . 10.1159/000544044 . GE - Portuguese Journal of Gastroenterology

Severe Reversible Heart Failure Enhanced by Sorafenib Treatment for Hepatocellular Carcinoma

Luís Guilherme Santos; Ricardo Roque; Rita Antunes Santos; Catarina Neves; Nuno Bonito, Cureus. 2025. http://dx.doi.org/10.7759/cureus.76993 . 10.7759/cureus.76993 . Cureus

Outcomes of Broader Genomic Profiling in Metastatic Colorectal Cancer: A Portuguese Cohort Study

Ricardo Roque; Rita Santos; Luís Guilherme Santos; Rita Coelho; Isabel Fernandes; Gonçalo Cunha; Marta Gonçalves; et al, DNA. 2025. https://doi.org/10.3390/dna5010004 . 10.3390/dna5010004 . DNA

Rare Becomes Rarer: Neuroendocrine Carcinoma of the Cervix With Synchronous Breast, Pancreatic, and Ovarian Metastases

Luís Guilherme Santos; Ricardo Roque; Rita Antunes Santos; Tatiana Pereira; Isabel Pazos, Cureus. 2024. http://dx.doi.org/10.7759/cureus.75144 . 10.7759/cureus.75144 . Cureus

Efficacy of cisplatin-gemcitabine-durvalumab in patients with advanced biliary tract cancer experiencing early vs late disease relapse after surgery: a large real-life worldwide population

Federica Lo Prinzi; Francesca Salani; Margherita Rimini; Mario Domenico Rizzato; Lorenzo Antonuzzo; Silvia Camera; Tomoyuki Satake; et al, The Oncologist. 2024. http://dx.doi.org/10.1093/oncolo/oyae256 . 10.1093/oncolo/oyae256 . The Oncologist

Menstrual Blood Stem Cells-Derived Exosomes as Promising Therapeutic Tools in Premature Ovarian Insufficiency Induced by Gonadotoxic Systemic Anticancer Treatment

Mariana Robalo Cordeiro; Ricardo Roque; Bárbara Laranjeiro; Carlota Carvalhos; Margarida Figueiredo-Dias, International Journal of Molecular Sciences. 2024. https://doi.org/10.3390/ijms25158468 . 10.3390/ijms25158468 . International Journal of Molecular Sciences

Current Applications and Challenges of Next-Generation Sequencing in Plasma Circulating Tumour DNA of Ovarian Cancer

Ricardo Roque; Ilda Ribeiro; Margarida Dias; Charlie Gourley; Isabel Marques Carreira; Roque Ricardo, Biology. 2024. http://dx.doi.org/10.3390/biology13020088 . 10.3390/biology13020088 . Biology

The impact of CDK4/6 inhibitors on the quality of life of working-age women with metastatic breast cancer: a population-based cohort study from Portugal [version 1; peer review: awaiting peer review]

Ana Caetano; Alda Tavares; Mariana Pires; Cláudia Costa; Joana Monteiro; Ricardo Roque; Rita Santos; et al, 2024. https://f1000research.com/articles/13-75/v1 . 10.12688/f1000research.142460.1 .

Impact of COVID-19 Pandemic on In-Hospital Mortality in Patients Without SARS-CoV-2 Infection in an Internal Medicine Ward of a Tertiary Care Hospital in Portugal

Ramalho, Ana Rita; Mendes, Ana Cristina; Camões, Guilherme; Roque, Ricardo; Moura, Pedro; Mateus-Pinheiro, António; Dias, Adriana; et al, Cureus. 2022. http://dx.doi.org/10.7759/cureus.32059 . 10.7759/cureus.32059 . Cureus

The accuracy of magnetic resonance imaging in predicting the size of pure ductal carcinoma in situ: a systematic review and meta-analysis

Roque, Ricardo; Robalo Cordeiro, Mariana; Armas, Mónica; Caramelo, Francisco; Caseiro-Alves, Filipe; Figueiredo-Dias, Margarida, npj Breast Cancer. 2022. https://doi.org/10.1038/s41523-022-00441-x . 10.1038/s41523-022-00441-x . npj Breast Cancer

Oligosecretory multiple myeloma: a devastating presentation of a difficult diagnosis

Ricardo Roque; Laura Machado; Duarte Flor; Francisca Cunha, BMJ Case Reports. 2021. https://doi.org/10.1136/bcr-2020-240404 . 10.1136/bcr-2020-240404 . BMJ Case Reports

Epithelial-mesenchymal interconversions in ovarian cancer: the levels and functions of E-cadherin in intraabdominal dissemination

Roque, Ricardo; Costa Sousa, Filipa; Figueiredo-Dias, Margarida, Oncology Reviews. 2020. http://dx.doi.org/10.4081/oncol.2020.475 . 10.4081/oncol.2020.475 . Oncology Reviews

All projects

Show less

Information of exclusive responsibility of the researcher 07-06-2026 , from platform CIÊNCIAVITAE.

2025

A phase 3 study of first-line sotorasib, panitumumab, and FOLFIRI versus FOLFIRI with or without bevacizumab-awwb for patients with KRAS G12C–mutated metastatic colorectal cancer (CodeBreaK 301)

NCT06252649

Researcher

2024 - 2025

Outcomes of broader genomic profiling of metastatic colorectal cancer

TI 26/2024

Principal investigator

2023 - 2024

OPAL STUDY: A PAN European Observational Cohort Study Describing Clinical Characteristics, Treatment Patterns and Outcomes in Patients Diagnosed With Hepatocellular Carcinoma (HCC)

D419CR00023

Researcher

AstraZeneca - Produtos Farmacêuticos LDA

2022

Unveiling predictive and prognostic biomarkers in advanced stage ovarian carcinoma using liquid biopsy (bioLOC)

TI 28/2022

PhD Student Fellow

Universidade de Coimbra Instituto de Investigação Clínica e Biomédica de Coimbra

2022 - 2022

PROOF Trial: Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations

NCT03773302

Researcher

QED Therapeutics Inc

2022 - 2024

A Study to Evaluate the Safety and Tolerability of Lenvatinib in Participants With Advanced or Unressectable Hepatocellular Carcinoma (STELLAR)

NCT0476340

Researcher

Eisai Corporation of North America

We use cookies to improve your visit to our website.